Product Information
BETASEPT 4% SURGICAL SCRUB is a generic product labeled by Atlantis Consumer Healthcare, Inc., priced at $0.0366 per ML under NDC 67618020008. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 24, 1984.
Strength
.04 mg/mL
Manufacturer
Atlantis Consumer Healthcare, Inc.NDC
67618020008
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CHLORHEXIDINE GLUCONATEApproval Type
New Drug (NDA)
FDA Application
NDA019125FDA Approved
12/24/1984
On Market Since
6/1/1993
Pharmacological Classes
Price Statistics
The NADAC for BETASEPT 4% SURGICAL SCRUB has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 63.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0366 per ML |
|---|---|
| All-time high | $0.0387 (Mar 11, 2026) |
| All-time low | $0.0165 (Apr 20, 2016) |
| 52-week high | $0.0387 |
| 52-week low | $0.0312 |
| Median price | $0.0180 |
| Average price | $0.0208 |
| Largest weekly change | +55.0% (Jan 20, 2016) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 52% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Atlantis Consumer Healthcare, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Antiseptic Surgical Scrub market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BETASEPT 4% SURGICAL SCRUB?
The current National Average Drug Acquisition Cost (NADAC) for BETASEPT 4% SURGICAL SCRUB, manufactured by Atlantis Consumer Healthcare, Inc., is $0.0366 per ML (NDC 67618020008), effective Sep 30, 2026.
How has the price of BETASEPT 4% SURGICAL SCRUB changed over time?
Over the history we have for it, the NADAC for BETASEPT 4% SURGICAL SCRUB has risen 63.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BETASEPT 4% SURGICAL SCRUB?
Since Nov 28, 2013, the NADAC for BETASEPT 4% SURGICAL SCRUB has ranged from a low of $0.0165 (Apr 20, 2016) to a high of $0.0387 (Mar 11, 2026), with a median of $0.0180 per ML.
Are there cheaper alternatives to BETASEPT 4% SURGICAL SCRUB?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BETASEPT 4% SURGICAL SCRUB, is $0.0178 per ML — about 52% below BETASEPT 4% SURGICAL SCRUB.
Who manufactures BETASEPT 4% SURGICAL SCRUB?
BETASEPT 4% SURGICAL SCRUB (NDC 67618020008) is labeled by Atlantis Consumer Healthcare, Inc., and CMS classifies it as a generic product.